BOOM
Citations are updated once a week. Recently added citations may not appear.
| Context | Citation |
|---|---|
| Ocimum gratissimum {Clove basil} - Staphylococcus aureus FVRH6118 |
👶
Impact of Microencapsulation on Ocimum gratissimum L. Essential Oil: Antimicrobial, Antioxidant Activities, and Chemical Composition. Foods (Basel, Switzerland) (Foods ) Vol: 13 Issue 19 Pages: Pub: 2024 Sep 30 Epub: 2024 Sep 30 Authors Granados ADPF , Duarte MCT , Noguera NH , Lima DC , Rodrigues RAF , Html Article Publication |
| Ocimum gratissimum {Clove basil} - Staphylococcus aureus FVRH6118 |
👶
Screening of crude extracts of six medicinal plants used in South-West Nigerian unorthodox medicine for anti-methicillin resistant Staphylococcus aureus activity. BMC complementary and alternative medicine (BMC Complement Altern Med ) Vol: 5 Issue Pages: 6 Pub: 2005 Mar 11 Epub: 2005 Mar 11 Authors Akinyemi KO , Oladapo O , Okwara CE , Ibe CC , Fasure KA , Html Article Publication |
| Ocimum gratissimum {Clove basil} - Staphylococcus aureus FVRH6118 |
👶
Modulation of the norfloxacin resistance in Staphylococcus aureus by Croton campestris A. and Ocimum gratissimum L. Biomedica : revista del Instituto Nacional de Salud (Biomedica ) Vol: 31 Issue 4 Pages: 608-12 Pub: 2011 Oct-Dec Epub: Authors Coutinho HD , Matias EF , Santos KK , Santos FA , Morais-Braga MF , Souza TM , Andrade JC , Souza CE , Tintino SR , Guedes GM , Falcão-Silva VS , Siqueira-Júnior JP , Costa JG , Publication |
| Ocimum gratissimum {Clove basil} - Staphylococcus aureus FVRH6118 |
👶
Characterization of essential oil from Ocimum gratissimum leaves: Antibacterial and mode of action against selected gastroenteritis pathogens. Microbial pathogenesis (Microb Pathog ) Vol: 118 Issue Pages: 290-300 Pub: 2018 May Epub: 2018 Mar 22 Authors Chimnoi N , Reuk-Ngam N , Chuysinuan P , Khlaychan P , Khunnawutmanotham N , Chokchaichamnankit D , Thamniyom W , Klayraung S , Mahidol C , Techasakul S , Publication |
BOOM
All suggestions are computed solely on their predicted microbiome impact. Safety, side-effects etc must be evaluated by your medical professionals before starting. Some items suggests have significant risk of adverse consequences for some people.
Special thanks to David F Morrison and Geert Van Houcke for doing Quality Assurance. Special thanks to Oliver Luk, B.Sc. (Biology) from BiomeSight for spot checking the coding of data from the US National Library of Medicine
This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.
Copyright 2016-2023 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 § 1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.
